Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Proto-oncogene tyrosine-protein kinase Src | ||
Ligand | BDBM50067535 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1465694 (CHEMBL3405455) | ||
Ki | 2500±n/a nM | ||
Citation | Boyd, MJ; Bandarage, UK; Bennett, H; Byrn, RR; Davies, I; Gu, W; Jacobs, M; Ledeboer, MW; Ledford, B; Leeman, JR; Perola, E; Wang, T; Bennani, Y; Clark, MP; Charifson, PS Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors. Bioorg Med Chem Lett25:1990-4 (2015) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Proto-oncogene tyrosine-protein kinase Src | |||
Name: | Proto-oncogene tyrosine-protein kinase Src | ||
Synonyms: | Calmodulin/Proto-oncogene tyrosine-protein kinase Src | Protein cereblon/Tyrosine-protein kinase SRC | Proto-oncogene c-Src | Proto-oncogene tyrosine-protein kinase Src (c-Src) | SRC | SRC1 | SRC_HUMAN | Tyrosine-protein kinase Src (SRC) | V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | c-Src | p60-Src | pp60c-src | ||
Type: | Protein | ||
Mol. Mass.: | 59838.60 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P12931 | ||
Residue: | 536 | ||
Sequence: |
| ||
BDBM50067535 | |||
n/a | |||
Name | BDBM50067535 | ||
Synonyms: | CHEMBL3401986 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H22F2N6O | ||
Mol. Mass. | 412.4358 | ||
SMILES | CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(ncc1F)-c1c[nH]c2ncc(F)cc12 |r,wU:11.13,wD:4.3,(3.45,3.56,;2.38,2.95,;1.05,3.73,;1.06,4.97,;-.29,2.98,;-1.7,3.76,;-3.03,2.98,;-3.03,1.41,;-1.7,.63,;-.96,1.7,;-2.37,2.68,;-.33,1.41,;.98,.59,;.93,-.95,;-.42,-1.67,;-.48,-3.21,;.83,-4.02,;2.19,-3.3,;2.24,-1.76,;3.33,-1.18,;-1.83,-3.93,;-2.01,-5.43,;-3.53,-5.71,;-4.26,-4.36,;-5.76,-4.01,;-6.19,-2.51,;-5.12,-1.4,;-5.47,-.22,;-3.61,-1.77,;-3.19,-3.25,)| | ||
Structure |